D. Johnson

发表

Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.

D. Johnson, A. Addington, D. Johnson, 1996, Biochemistry.

Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor.

D. Johnson, J. Travis, D. Johnson, 1978, The Journal of biological chemistry.

The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum.

E. Frieden, D. Johnson, S. Osaki, 1966, The Journal of biological chemistry.

Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma.

D. Johnson, J. Travis, D. Tewksbury, 1976, The Biochemical journal.

The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I.

E. Frieden, D. Johnson, S. Osaki, 1971, The Journal of biological chemistry.

The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center.

D. Johnson, J. Travis, D. Johnson, 1979, The Journal of biological chemistry.

The effect of the steroid sulfatase inhibitor (p-O-sulfamoyl)-tetradecanoyl tyramine (DU-14) on learning and memory in rats with selective lesion of septal–hippocampal cholinergic tract

D. Johnson, N. Fitz, R. Gibbs, 2012, Neurobiology of Learning and Memory.

Human alpha-1-proteinase inhibitor mechanism of action: evidence for activation by limited proteolysis.

D. Johnson, J. Travis, D. Johnson, 1976, Biochemical and biophysical research communications.

Mobilization of liver iron by ferroxidase (ceruloplasmin).

D. Johnson, S. Osaki, D. Johnson, 1969, The Journal of biological chemistry.

Mechanisms and pathways from recent deoxysugar biosynthesis research.

D. Johnson, H. Liu, D. Johnson, 1998, Current opinion in chemical biology.

The carboxy terminal sequence of human alpha-1-proteinase inhibitor.

D. Johnson, J. Travis, D. Johnson, 1978, Biochemical and biophysical research communications.

Purification and properties of rabbit trypsin.

D. Johnson, D. Johnson, 1976, Biochimica et biophysica acta.

Fluorescence energy transfer between cysteine 199 and cysteine 343: evidence for MgATP-dependent conformational change in the catalytic subunit of cAMP-dependent protein kinase.

S. Taylor, E. A. First, D. Johnson, 1989, Biochemistry.

Molecular cloning and characterization of mouse mast cell chymases.

D. Johnson, P. Musich, W. Chu, 1992, Biochimica et biophysica acta.

Multiphoton dissociation of some volatile uranyl complexes. I. The phenomena of reversible and permanent dissociation

R. Knott, J. Eberhardt, A. Pryor, 1982 .

A micromethod for the determination of ferroxidase (ceruloplasmin) in human serums.

E. Frieden, D. Johnson, S. Osaki, 1967, Clinical chemistry.

2.P.40 Discovery of the squalene synthetase inhibitor CP-340,868

C. Aldinger, H. J. Harwood, S. Petras, 1997 .

Production of macrophage activation factors by tryptic cleavage of calf serum proteins

D. Johnson, M. C. McDaniel, M. Tucker, 1983, Inflammation.

Ozone, but not nitrogen dioxide, fragments elastin and increases its susceptibility to proteolysis.

D. Johnson, R. Winters, B. Burnette-Vick, 1994, American journal of respiratory and critical care medicine.

The effect of bovine lactoferrin on muscle growth in vivo and in vitro.

P. Comens, D. Johnson, R. Collier, 1990, Biochemical and biophysical research communications.

Caffeine potentiates the enhancement by choline of striatal acetylcholine release.

R. Wurtman, D. Johnson, I. Ulus, 1992, Life sciences.

Interaction of noncompetitive inhibitors with the acetylcholine receptor. The site specificity and spectroscopic properties of ethidium binding.

P. Taylor, D. Johnson, J. Herz, 1987, The Journal of biological chemistry.

Studies of Topochemical Heterogeneous Catalysis

D. Johnson, G. Batley, A. Ekstrom, 1975 .

The thermodynamics of aqueous borate solutions I. Mixtures of boric acid with sodium or potassium borate and chloride

R. N. Roy, D. Johnson, David A Johnson, 1987 .

Nonenzymatic conversion of penicillins to 6-aminopenicillanic acid.

R. R. Smith, D. Johnson, C. Panetta, 1966, The Journal of organic chemistry.

Recent Advances in the Chemistry of the Less-Common Oxidation States of the Lanthanide Elements

D. Johnson, D. Johnson, 1977 .

The histrionicotoxin-sensitive ethidium binding site is located outside of the transmembrane domain of the nicotinic acetylcholine receptor: a fluorescence study.

D. Johnson, J. Nuss, D. Johnson, 1994, Biochemistry.

Ozone inactivation of human alpha 1-proteinase inhibitor.

D. Johnson, D. Johnson, 1980, The American review of respiratory disease.

Mitomycin resistance in mammalian cells expressing the bacterial mitomycin C resistance protein MCRA.

D. Sherman, S. Rockwell, A. Sartorelli, 1999, Proceedings of the National Academy of Sciences of the United States of America.

The kinetics and mechanism of the reaction of U(VI) with 4-(2-pyridylazo) resorcinol (PAR)

D. Johnson, A. Ekstrom, D. Johnson, 1974 .

Cathepsin L inactivates alpha 1-proteinase inhibitor by cleavage in the reactive site region.

A. Barrett, D. Johnson, R. Mason, 1986, The Journal of biological chemistry.

A deuterium NMR and steady-state fluorescence anisotropy study of the effects of cholesterol on the lipid membrane-disordering actions of ethanol.

C. Valenzuela, D. Johnson, R. Zidovetzki, 1992, Biochemical pharmacology.

Regulation of cAMP-dependent protein kinase: enzyme activation without dissociation.

D. Johnson, W. Fletcher, S. Yang, 1995, Biochemistry.

Human pituitary tryptase: molecular forms, NH2-terminal sequence, immunocytochemical localization, and specificity with prohormone and fluorogenic substrates.

N. Seidah, M. Marcinkiewicz, M. Chrétien, 1987, The Journal of biological chemistry.

Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs).

C. L. Johnson, D. Johnson, J. Ward, 1999, Bioorganic & medicinal chemistry letters.

Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases.

D. Johnson, C. E. Smith, D. Johnson, 1985, The Biochemical journal.

Fluorescence resonance energy transfer within a heterochromatic cAMP-dependent protein kinase holoenzyme under equilibrium conditions: new insights into the conformational changes that result in cAMP-dependent activation.

D. Walsh, D. Johnson, D A Johnson, 1993, Biochemistry.

Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption.

M. Stack, D. Johnson, V. Thomas, 1998, Biochemistry.

Bronchial leukocyte proteinase inhibitor: hydrodynamic properties and interaction with alpha 2-macroglobulin-bound elastase.

M. Stack, D. Johnson, W. Dean, 1988, Archives of biochemistry and biophysics.

Sodium dodecyl sulfate enhancement of quantitative immunoenzyme dot-blot assays on nitrocellulose.

D. Johnson, P. Musich, C. E. Smith, 1989, Analytical biochemistry.

Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase.

D. Johnson, W. Dralle, B. Carter-Hamm, 1982, The American review of respiratory disease.

Human kininogens.

A. Barrett, G. Salvesen, D. Johnson, 1988, Methods in enzymology.

Solute accessibility to N epsilon-fluorescein isothiocyanate-lysine-23 cobra alpha-toxin bound to the acetylcholine receptor. A consideration of the effect of rotational diffusion and orientation constraints on fluorescence quenching.

D. Johnson, J. Yguerabide, D. Johnson, 1985, Biophysical journal.

Ozone effects on inhibitors of human neutrophil proteinases.

M. Stack, D. Johnson, C. E. Smith, 1987, Archives of biochemistry and biophysics.

Ethanol-induced fluidization of brain lipid bilayers: required presence of cholesterol in membranes for the expression of tolerance.

R. Cooke, H. Loh, D. Johnson, 1979, Molecular pharmacology.

Inactivation of human alpha 1-proteinase inhibitor by thiol proteinases.

J. Travis, D. Johnson, 1977, The Biochemical journal.